A meta-analysis of CAG (cytarabine, aclarubicin, G-CSF) regimen for the treatment of 1029 patients with acute myeloid leukemia and myelodysplastic syndrome

The regimen of cytarabine, aclarubicin and G-CSF (CAG) has been widely used in China and Japan for treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). We searched literature on CAG between 1995 and 2010 and performed a meta-analysis to determine its overall efficacy using a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Guoqing, Ni, Wanmao, Chiao, Jen-wei, Cai, Zhen, Huang, He, Liu, Delong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230125/
https://www.ncbi.nlm.nih.gov/pubmed/22082134
http://dx.doi.org/10.1186/1756-8722-4-46

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230125/
https://www.ncbi.nlm.nih.gov/pubmed/22082134
http://dx.doi.org/10.1186/1756-8722-4-46

Ejemplares similares